Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|November 9, 2025
10-year survival after resection of pancreatic ductal adenocarcinoma with pathological re-examination of a nationwide cohortE M M Verkolf, E N Dekker, L G van der Geest, et al.
Annals of Surgical Oncology|June 27, 2024
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide StudyI W J M van Goor, P C M Andel, F S Buijs, et al.
Trials|June 20, 2024
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 14, 2020
The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registryL J H Brada, M S Walma, R M van Dam, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysisJ C M Scheepens, K J Prinsze, L G van Geest, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 16, 2020
Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysisL A Daamen, I W J M van Goor, T J Schouten, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2025
Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysisP C M Andel, I W J M van Goor, N C Biesma, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
Kidney Medicine|January 8, 2026
Symptom Burden and Patient-Reported Outcomes in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort StudiesNiels L Riemersma, Tim J Knobbe, Daan Kremer, et al.
BMC Cancer|February 19, 2025
Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocolT F Stoop, L W F Seelen, F R van 't Land, et al.
Pageof 3